#5: NewsBot: Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase... |
December 13, 2007
10:12:38 AM |
#4: FastFun: Rigel to Present Research Programs at Scientific Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Rigel... |
October 17, 2007
10:16:18 PM |
#3: FastFun: Rigel to Present at BIO Investor Forum 2007
SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Rigel... |
October 17, 2007
10:14:52 PM |
#2: FastFun: Rigel Announces Presentations at Two Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Rigel... |
October 17, 2007
10:14:08 PM |
#1: FastFun: (OTC: VMCS) Segal Cancer Center Selects VisualMED
OTC: VMCS) Segal Cancer Center Selects VisualMEDVisualMED Clinical Solutions Corp.... |
October 17, 2007
10:13:34 PM |
|
Tips for using stock message boards discussion forums
|
| 
| 
| 
| 
| 
| 
